Clinical trial
Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
NCT03942601 is registered in ClinicalTrials.gov with Mercator MedSystems, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
- Lead sponsor
- Mercator MedSystems, Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- October 1, 2019
- Completion date
- April 30, 2021
- Enrollment
- 10 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.